Verition Fund Management
BIIB icon

Verition Fund Management’s Biogen BIIB Stock Holding History

Verition Fund Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-160,000
Closed -$21.9M – 3640
2025
Q1 		$21.9M Hold
160,000
– – 0.1% 188
2024
Q4 		$24.5M Buy
160,000
+152,100
+1,925% +$25.7M 0.1% 177
2024
Q3 		$1.53M Hold
7,900
– – 0.01% 1593
2024
Q2 		$1.83M Sell
7,900
-1,100
-12% -$239K 0.01% 1322
2024
Q1 		$1.94M Buy
9,000
+4,100
+84% +$960K 0.01% 1228
2023
Q4 		$1.27M Sell
4,900
-200
-4% -$49.1K 0.01% 1055
2023
Q3 		$1.31M Buy
+5,100
New +$1.36M 0.02% 960
2022
Q4 		– Sell
-3,500
Closed -$935K – 2166
2022
Q3 		$935K Buy
+3,500
New +$743K 0.01% 1450
2022
Q2 		– Sell
-2,600
Closed -$548K – 2377
2022
Q1 		$548K Buy
+2,600
New +$565K 0.01% 1857
2021
Q4 		– Sell
-2,700
Closed -$764K – 2544
2021
Q3 		$764K Buy
+2,700
New +$885K 0.01% 1046

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Verition Fund Management's BIIB Position: Q1 2026 in Review

Verition Fund Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 18,523 shares — an estimated $3.26M sold.

Verition Fund Management first reported a position in BIIB in Q2 2013 and held it in 41 quarters. The position peaked at $54.5M in Q3 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Verition Fund Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 18,523 Biogen shares in Q1 2026, an estimated $3.26M.
  • Verition Fund Management first reported a position in Biogen in Q2 2013 and held it in 41 quarters.
  • Verition Fund Management's Biogen position peaked at $54.5M in Q3 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.